Debra L Davenport, MA, SPE in Camden, TN - Psychologist

Debra L Davenport, MA, SPE is a Psychologist based in Camden, Tennessee. Debra L Davenport is licensed to practice in Tennessee (license number PE 11334) and her current practice location is 198 W Main St, Camden, Tennessee. She can be reached at her office (for appointments etc.) via phone at (731) 584-1012.

NPI number for Debra L Davenport is 1831221944 and her current mailing address is 12595 Highway 69a, Big Sandy, Tennessee. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1831221944.

Contact Information

	Debra L Davenport, MA, SPE
	198 W Main St, Camden, TN 38320-1609
	(731) 584-1012
	(731) 584-3102

Healthcare Provider's Profile

Full Name	Debra L Davenport
Gender	Female
Speciality	Psychologist
Location	198 W Main St, Camden, Tennessee
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1831221944
Provider Enumeration Date: 03/12/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Debra L Davenport such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1831221944	NPI	-	NPPES
5441084	Medicaid	TN

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103T00000X	Psychologist	PE 11334 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Debra L Davenport is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Debra L Davenport, MA, SPE 12595 Highway 69a, Big Sandy, TN 38221-5066 Ph: (731) 584-1012	Debra L Davenport, MA, SPE 198 W Main St, Camden, TN 38320-1609 Ph: (731) 584-1012

News Archive

Merus Labs International acquires rights to manufacture, market specialty pharmaceutical products in multiple countries

Merus Labs International Inc. is pleased to announce that one of its wholly owned subsidiaries has signed a definitive agreement to acquire the rights to manufacture, market, and sell two established specialty pharmaceutical products in certain European and other markets.

Questions raised about vertebroplasty for osteoporotic spinal compression fractures

A new study led by Mayo Clinic researchers has found that relief of pain from vertebral compression fractures, as well as improvement in pain-related dysfunction, were similar in patients treated with vertebroplasty and those treated with simulated vertebroplasty without cement injections. The article, "A Randomized Controlled Trial of Vertebroplasty for Osteoporotic Spine Fractures," was released today in the New England Journal of Medicine.

Autism - MMR vaccine has it's day in court

A test case in an American court could in one way or another settle the debate on the possible link between autism and childhood vaccines.

Study identifies new factor that offers potential strategy for treating obesity

Obesity is a serious global health problem and a risk factor for diseases such as type II diabetes, heart disease and fatty liver disease.

Debra L Davenport, MA, SPE - Psychologist in Camden, TN